Literature DB >> 5903172

Relationship of phthalanilide-lipid complexes to uptake and retention of 2-chloro-4',4"-di(2-imidazolin-2-yl)terephthalanilide (NSC 60339) by sensitive and resistant P388 leukemia cells.

D W Yesair, F A Kohner, W I Rogers, P E Baronowsky, C J Kensler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5903172

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

Review 1.  ABC transporters and their role in nucleoside and nucleotide drug resistance.

Authors:  Yu Fukuda; John D Schuetz
Journal:  Biochem Pharmacol       Date:  2012-01-20       Impact factor: 5.858

2.  Identification and Structure-Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coli.

Authors:  Keith M Haynes; Narges Abdali; Varsha Jhawar; Helen I Zgurskaya; Jerry M Parks; Adam T Green; Jerome Baudry; Valentin V Rybenkov; Jeremy C Smith; John K Walker
Journal:  J Med Chem       Date:  2017-07-11       Impact factor: 7.446

3.  Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.

Authors:  Narges Abdali; Jerry M Parks; Keith M Haynes; Julie L Chaney; Adam T Green; David Wolloscheck; John K Walker; Valentin V Rybenkov; Jerome Baudry; Jeremy C Smith; Helen I Zgurskaya
Journal:  ACS Infect Dis       Date:  2016-11-02       Impact factor: 5.084

Review 4.  Terephthalamidine: past and future.

Authors:  J S Fisherman; E M Cline; J Plowman; F R Quinn; M J Hawkins
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

Review 5.  Nonintercalative DNA-binding antitumour compounds.

Authors:  B C Baguley
Journal:  Mol Cell Biochem       Date:  1982-04-02       Impact factor: 3.396

6.  A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion.

Authors:  G I Rodriguez; J G Kuhn; G Weiss; P De La Cruz; P New; S M Fields; J R Eckardt; L Campbell; G M Clark; S G Hilsenbeck; D D Von Hoff
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.